Chardan Healthcare Acquisition 2 Corp.’s Merger with Renovacor

Latham & Watkins represented Chardan Healthcare Acquisition 2 Corp. in the transaction. Renovacor, Inc. (Renovacor), an early-stage biotechnology company developing AAV-based gene therapies for devastating cardiovascular...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Beacon Street Group’s $3 Billion de-SPAC Combination with Ascendant Digital Acquisition Corp.

Latham & Watkins represented Beacon Street Group in the transaction. Beacon Street Group, LLC, a leading multi-brand digital subscription services platform that provides premium financial research,...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here